Accepted for/Published in: JMIR Human Factors
Date Submitted: Jul 22, 2024
Open Peer Review Period: Aug 12, 2024 - Oct 7, 2024
Date Accepted: Aug 12, 2025
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Mobile Health Utilization, Preferences, Barriers, and eHealth Literacy among Patients with Inflammatory Bowel Disease (IBD): A Patient Survey Study
ABSTRACT
Background:
Mobile Health (mHealth), which refers to health care facilitated by mobile devices, offers a promising strategy for enhancing disease management and treatment for patients with chronic conditions. However, there is limited information on how patients with inflammatory bowel disease (IBD) utilize mHealth and their digital preferences.
Objective:
The aim of the study was to investigate the utilization of mHealth, as well as the preferences, obstacles, and eHealth literacy as reported by patients with IBD in Germany.
Methods:
From April to May 2023, we sequentially enrolled patients diagnosed with inflammatory bowel disease, such as Crohn´s disease and ulcerative colitis, to participate in a paper-based survey. The survey encompassed inquiries covering sociodemographic details, health characteristics, mHealth utilization, internet usage, eHealth literacy measured through the eHealth Literacy Scale (eHEALS), and preferences related to communication and information.
Results:
Out of the 200 surveyed participants, almost all individuals (197/200, 98.5%) reported regular smartphone usage, and more than half indicated regular engagement with social media (139/200, 69.5%). Most respondents (168/200, 84.0%) expressed the belief that incorporating medical apps into their routine could positively impact their health. However, only 25 out of 200 patients (12.5%) acknowledged using medical apps, amongst which only two apps were IBD-specific, used by 3 out of 25 participants (12.0%). Furthermore, awareness of useful websites or mobile applications specifically tailored for IBD was limited (45/200, 22.5%). An overwhelming majority of participants (196/200, 98.0%) affirmed their willingness to share data from mobile apps for research purposes. Consent to the transmission of app data to treating physicians was also high (171/200, 85.5%). Most patients (175/200, 87.5%) conveyed a readiness to regularly input data through an application with a preferred duration of up to 5 minutes (109/200, 54.5%) and a frequency of weekly input (76/200, 38.0%). Regarding functions for an IBD-specific app, participants’ most frequent requests were related to electronic prescription (55.0%) and a newsletter about new scientific work and clinical studies (47.0%). Favored key attributes of an app were usability and security. When seeking health-related information, the internet emerged as the predominant source (180/200, 90%). The average eHealth literacy was reported to be high (28.9/40), with a positive correlation observed between higher eHealth literacy and factors such as younger age and more frequent internet usage to receive health information.
Conclusions:
Patients with IBD are well-qualified and motivated to use mHealth technologies to better understand their chronic condition and optimize their treatment. However, their enthusiasm is curbed by the low actual adoption of mHealth. To fully harness the potential of mHealth in IBD treatment, effective and tailored mHealth solutions, implementation recommendations, and patient education are needed.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.